BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29049482)

  • 41. Diagnostic stability 18 months after treatment initiation for first-episode psychosis.
    Schimmelmann BG; Conus P; Edwards J; McGorry PD; Lambert M
    J Clin Psychiatry; 2005 Oct; 66(10):1239-46. PubMed ID: 16259537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale.
    Lindenmayer JP; Bossie CA; Kujawa M; Zhu Y; Canuso CM
    Psychopathology; 2008; 41(4):264-70. PubMed ID: 18441528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuum.
    Sabaroedin K; Razi A; Chopra S; Tran N; Pozaruk A; Chen Z; Finlay A; Nelson B; Allott K; Alvarez-Jimenez M; Graham J; Yuen HP; Harrigan S; Cropley V; Sharma S; Saluja B; Williams R; Pantelis C; Wood SJ; O'Donoghue B; Francey S; McGorry P; Aquino K; Fornito A
    Brain; 2023 Jan; 146(1):372-386. PubMed ID: 35094052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cortical stress regulation is disrupted in schizophrenia but not in clinical high risk for psychosis.
    Schifani C; Tseng HH; Kenk M; Tagore A; Kiang M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Brain; 2018 Jul; 141(7):2213-2224. PubMed ID: 29860329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic stability of first-episode psychosis and predictors of diagnostic shift from non-affective psychosis to bipolar disorder: a retrospective evaluation after recurrence.
    Kim JS; Baek JH; Choi JS; Lee D; Kwon JS; Hong KS
    Psychiatry Res; 2011 Jun; 188(1):29-33. PubMed ID: 21056477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Early intervention in bipolar affective disorders: Why, when and how].
    Pouchon A; Fakra E; Haesebaert F; Legrand G; Rigon M; Schmitt E; Conus P; Bougerol T; Polosan M; Dondé C
    Encephale; 2022 Feb; 48(1):60-69. PubMed ID: 34565543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychosocial function in schizophrenia and bipolar disorder: Relationship to neurocognition and clinical symptoms.
    Simonsen C; Sundet K; Vaskinn A; Ueland T; Romm KL; Hellvin T; Melle I; Friis S; Andreassen OA
    J Int Neuropsychol Soc; 2010 Sep; 16(5):771-83. PubMed ID: 20509984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations.
    Zanelli J; Reichenberg A; Morgan K; Fearon P; Kravariti E; Dazzan P; Morgan C; Zanelli C; Demjaha A; Jones PB; Doody GA; Kapur S; Murray RM
    Am J Psychiatry; 2010 Jan; 167(1):78-85. PubMed ID: 19952077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis.
    Gouvea ES; Ota VK; Noto C; Santoro ML; Spindola LM; Moretti PN; Carvalho CM; Xavier G; Rios AC; Sato JR; Hayashi MA; Brietzke E; Gadelha A; Bressan RA; Cordeiro Q; Belangero SI
    Transl Psychiatry; 2016 Oct; 6(10):e908. PubMed ID: 27701407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Boundaries of schizoaffective disorder: revisiting Kraepelin.
    Kotov R; Leong SH; Mojtabai R; Erlanger AC; Fochtmann LJ; Constantino E; Carlson GA; Bromet EJ
    JAMA Psychiatry; 2013 Dec; 70(12):1276-86. PubMed ID: 24089086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis.
    Bowie CR; Best MW; Depp C; Mausbach BT; Patterson TL; Pulver AE; Harvey PD
    Bipolar Disord; 2018 Nov; 20(7):604-613. PubMed ID: 29777563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study.
    Howes O; Bose S; Turkheimer F; Valli I; Egerton A; Stahl D; Valmaggia L; Allen P; Murray R; McGuire P
    Mol Psychiatry; 2011 Sep; 16(9):885-6. PubMed ID: 21358709
    [No Abstract]   [Full Text] [Related]  

  • 54. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.
    Mathew I; Gardin TM; Tandon N; Eack S; Francis AN; Seidman LJ; Clementz B; Pearlson GD; Sweeney JA; Tamminga CA; Keshavan MS
    JAMA Psychiatry; 2014 Jul; 71(7):769-77. PubMed ID: 24828364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.
    Schifani C; Hafizi S; Tseng HH; Gerritsen C; Kenk M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Schizophr Res; 2019 Nov; 213():80-86. PubMed ID: 30409695
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?
    Craig TJ; Bromet EJ; Fennig S; Tanenberg-Karant M; Lavelle J; Galambos N
    Am J Psychiatry; 2000 Jan; 157(1):60-6. PubMed ID: 10618014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The metabolic basis of psychosis in bipolar disorder: A positron emission tomography study.
    Marotta G; Delvecchio G; Pigoni A; Mandolini G; Ciappolino V; Oldani L; Madonna D; Grottaroli M; Altamura AC; Brambilla P
    Bipolar Disord; 2019 Mar; 21(2):151-158. PubMed ID: 30506616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis.
    Roiser JP; Howes OD; Chaddock CA; Joyce EM; McGuire P
    Schizophr Bull; 2013 Nov; 39(6):1328-36. PubMed ID: 23236077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.